This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 11, 2013




















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 


AREA & ASSOCIATION NEWS

APhA Diabetes Certificate Training Program
AzPA
Date: Jan. 24
Time: 8 a.m. to 5 p.m.

Pharmacist and Patient-Centered Diabetes Care Certificate Training Program is an innovative and intensive certificate program that focuses on the pharmacist's role in the area of diabetes management. The program, which emphasizes a healthcare team approach, seeks to foster the implementation of pharmaceutical care interventions that will promote disease self-management.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




The holidays are just around the corner ...
AzPA



The holidays are coming quickly! Purchase your gift cards from the Arizona Pharmacy Foundation and support pharmacy education.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Pharmacy Packaging Solutions

Medical Packaging Inc. (MPI) is a leading manufacturer of unit-dose pharmacy packaging solutions for oral solids, liquids, and ampoules, vials and syringes.   Coupled with our exclusive Pak-EDGE™ UD Barcode Labeling Software, MPI’s solutions assist the hospital pharmacy in minimizing medication errors, increasing operational efficiency, and decreasing costs.
 


PHARMACY UPDATES


COAG and EU-PACT: The pharmacogenetics of warfarin dosing
Medscape (free subscription)
The two trials are EU-PACT, from the U.K. and Europe, and the COAG trial, which really emanated from the U.S. We know that warfarin has a very narrow therapeutic index, and in fact one-third of emergency-room visits due to adverse drug reactions is due to warfarin; therefore, the FDA has emphasized that warfarin dosing should be carefully made based on INR, but specifically the dosing recommendations in the drug labeling information are based on the genotype of patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword WARFARIN.


As compounding law passes, split views persist
Pharmacy Practice News
The Drug Quality and Security Act, which aims to close holes in the regulation of compounding pharmacies, was recently voted into law. Both the House of Representatives and the Senate passed the bill by a voice vote. Speaking from the Senate floor on Nov. 12, Sen. Harry Reid (D-Nev.) called the bill “a matter of life and death,” referring to 2012’s deadly outbreak of fungal meningitis traced back to the New England Compounding Center.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Clock is ticking: New acetaminophen combo limitations coming soon
By Jason Poquette
Beginning in January, manufacturers of combination prescription products containing acetaminophen are expected to limit their APAP content to no more than 325 mg per dose. The significance of this is that many narcotic combination products currently being dispensed will soon no longer be compliant with these guidelines. The most significant impact for this group would be the changes related to hydrocodone/acetaminophen combination products, many of which still contain 500 mg of APAP or more.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Bedtime aspirin may be more beneficial for heart patients (Pharmacy Times)
Cannabidiol: Medical miracle or shameful street drug? (By Maria Frisch)
AHRQ and ISMP introduce new medication safety tools (PQA Pharmacy Quality Alliance)
NCBDE announces changes regarding initial certification effective 2014 (NCBDE)
Needle tips and vaccination information (The Pharmacy Blog)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


Sofosbuvir for hepatitis C: Simpler, shorter, safer?
Medscape (free subscription)
In 2011, the American Association for the Study of Liver Diseases issued an updated version of its practice guidelines for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection. The current standard-of-care regimens include a protease inhibitor — telaprevir or boceprevir — in combination with pegylated interferon and ribavirin. Protease inhibitor-based strategies for patients with genotype 1 HCV have led to high rates of sustained virologic response; however, there are several recurring concerns.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Reducing the burn: Choosing the optimal local anesthetic for peripheral IV catheter placements
Pharmacy Practice News
During a hospitalization, patients often have a peripheral intravenous (PIV) catheter placed for medication administration. The placement of a PIV can cause discomfort for patients that may contribute to their anxiety when undergoing this procedure. Many health systems use local anesthetics as premedications to alleviate this distress. Choosing an ideal local anesthetic, however, can be a challenge, given the overall lack of evidence in this area.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



Vitamin D supplements won't help prevent disease
Health Day
Low levels of vitamin D have been implicated as a potential cause of diseases ranging from cancer to diabetes. Now an extensive review suggests it's really the other way around: Low levels of the "sunshine vitamin" are more likely a consequence — not a cause — of illness.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CDC: Threefold increase in measles warrants vigilance
Medscape
A threefold increase in U.S. measles cases in 2013 highlights the need to overcome fear of vaccination in this country and vanquish the deadly virus in other countries so it cannot spread here, the head of the Centers for Disease Control and Prevention said. Public health authorities have made tremendous progress in controlling measles, but "we're not anywhere over the finish line," said CDC Director Thomas Frieden.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Pediatricians urged to prescribe antibiotics carefully
Pharmacy Times
According to a new report released by the American Academy of Pediatrics and the Centers for Disease Control and Prevention, prescribers and parents should think twice before using antibiotics to treat upper respiratory tract infections in children.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
FDA introduces plan, proposed rule for drug shortages
American Society of Health-System Pharmacists
The FDA recently rolled out a strategic plan and a proposed rule that are meant to avert drug shortages and lessen the effects of shortages when they do occur.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Bedtime aspirin may be more beneficial for heart patients
Pharmacy Times
Aspirin may offer better protection against adverse events in cardiovascular disease patients when taken at night than when taken in the morning, new research suggests.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


Is it time to cap chemo Rx in advanced lung cancer?
Pharmacy Practice News
A year ago, Leigh Boehmer, PharmD, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, Miss. saw a patient with metastatic non-small cell lung cancer who had complete hearing loss in his right ear, an acute kidney injury, and a serum sodium level of 114. Despite these clear signs of chemotoxicity, Dr. Boehmer was astounded to find that the man had received 16 cycles of cisplatin-paclitaxel. And yet the first question asked by the patient, despite his overly aggressive therapy, was, “When do I get cycle number 17? It is due today.”
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Clobazam linked to serious skin reactions
ASHP
The antiseizure drug clobazam has been associated with potentially deadly skin reactions, according to a new Drug Safety Communication from the FDA. The agency stated Dec. 3, that it is aware of 21 cases worldwide of Stevens-Johnson syndrome and toxic epidermal necrolysis occurring in patients treated with clobazam, including 1 patient who became blind and 2 who died.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Slower brain connections may be at root of dyslexia
Health Day
Glitches in the connections between certain brain areas may be at the root of the common learning disorder dyslexia, a new study suggests. It's estimated that up to 15 percent of the U.S. population has dyslexia, which impairs people's ability to read. While it has long been considered a brain-based disorder, scientists have not understood exactly what the issue is.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Hemophilia B: Long-acting factor IX may be big improvement
Medscape (free subsciption)
A long-acting coagulation factor treatment of patients with hemophilia B is safe and effective for preventing bleeding events, according to an article published online Dec. 4 and in the Dec. 12 issue of the New England Journal of Medicine. Jerry S. Powell, M.D., from the University of Calif. at Davis, and colleagues conducted a nonrandomized, open-label phase 3 trial of the safety, efficacy, and pharmacokinetics of a recombinant factor IX fragment crystallizable fusion protein. They enrolled 123 previously treated male patients (aged 12 years and older) with severe hemophilia B.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Dec. 11, 2013
Dec. 4, 2013
Nov. 27, 2013
Nov. 20, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063